STEVEN VANDERBILT: Open Payments
NPI 1063977965 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 142 payments from 20 companies in 2025. Trend: 2023 $2,484 · 2024 $1,829 · 2025 $2,137
Food & beverage: $2,137
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $346 |
| Otsuka America Pharmaceutical, Inc. | 15 | $304 |
| ABBVIE INC. | 26 | $298 |
| AstraZeneca Pharmaceuticals LP | 8 | $251 |
| Lilly USA, LLC | 19 | $200 |
| Amgen Inc. | 12 | $140 |
| Astellas Pharma US Inc | 4 | $105 |
| Novo Nordisk Inc | 6 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $80 |
| Lundbeck LLC | 4 | $74 |
Products named: REXULTI, NURTEC ODT, UBRELVY, BREZTRI, Veozah, MOUNJARO, ELIQUIS, Kerendia.
Industry payments across AR — which companies pay providers there.
